ISSN 1006-298X      CN 32-1425/R

Chinese Journal of Nephrology, Dialysis & Transplantation ›› 2024, Vol. 33 ›› Issue (2): 182-186.DOI: 10.3969/j.issn.1006-298X.2024.02.016

Previous Articles     Next Articles

Progress in treatment of antineutrophil cytoplasmic antibodyassociated vasculitis by antibodyclearance blood purification technology#br#
#br#

  

  • Online:2024-04-28 Published:2024-04-23

Abstract: Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a multisystem autoimmune disease with a high mortality and risk of progresses to end-stage kidney disease(ESKD). In addition to glucocorticoids and immunosuppressants, extracorporeal blood purification techniques have become essential adjuncts for the treatment of AAV, including plasma exchange, double-filtration plasmapheresis and immunoadsorption. In this study, the progress of antibody scavenging blood purification technology in the treatment of AAV and the changes of guidelines were systematically reviewed, so as to provide a reference for clinical treatment.


Key words: anti-neutrophil cytoplasmic antibody-associated vasculitis, plasma exchange, double-filtration plasmapheresis, immunoadsorption, antibody purification